Target intelligence / Profile preview

Pancreatic beta-cell identity and function genes

Molecular classification
Transcription factor, Hormone, Transporter, Enzyme
01

Overview

Pancreatic beta-cell identity and function genes represent a coordinated network of transcription factors and functional proteins essential for maintaining the mature state and glucose-responsive insulin secretion of beta cells [Source: PubMed PMC5565123]. Key components include transcription factors like Pancreatic and duodenal homeobox 1 (PDX1), MAF BZIP Transcription Factor A (MAFA), and NK6 Homeobox 1 (NKX6.1), which drive the expression of the insulin gene (INS) and glucose sensors like SLC2A2 [Source: Genes & Development, 31(14), 1411-1422]. In Type 2 Diabetes, these genes are often downregulated, leading to beta-cell dedifferentiation where cells lose their specialized function and revert to a less mature state [Source: Cell, 150(6), 1223-1234]. This loss of identity is a major driver of disease progression and insulin insufficiency. Therapeutic interventions, such as GLP-1 receptor agonists, aim to preserve or restore the expression of these identity genes to maintain functional beta-cell mass [Source: Nature Reviews Endocrinology, 13(11), 635-651]. Although this is a collective gene set rather than a single molecular target, it serves as a critical framework for developing regenerative therapies and understanding islet pathophysiology.

Other names
Beta-cell signature genesBeta-cell maturation genesBeta-cell transcription factorsIslet-specific genes
02

Mechanism of action

Activation of signaling pathways that stabilize the expression of beta-cell-specific transcription factors and functional proteins to prevent dedifferentiation and maintain insulin secretion.

03

Biological functions

Insulin secretionGlucose homeostasisCell differentiationCell identity maintenance
04

Disease associations

Type 2 Diabetes MellitusType 1 Diabetes MellitusHyperinsulinemic hypoglycemia
05

Safety considerations

Risk of hypoglycemiaPotential for off-target cellular transdifferentiationOncogenic potential of transcription factor over-activationComplexity of targeting multi-gene networks
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

Insulin (INS)Pancreatic and duodenal homeobox 1 (PDX1)MAF BZIP Transcription Factor A (MAFA)NK6 Homeobox 1 (NKX6.1)Glucose transporter 2 (SLC2A2)Chromogranin A (CHGA)

Beyond the preview

Go deeper on Pancreatic beta-cell identity and function genes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pancreatic beta-cell identity and function genes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call